![Li Deng-Ke](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Loopbaan van Li Deng-Ke
Eerdere bekende functies van Li Deng-Ke
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
RICH PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 29-04-2011 | 29-03-2013 |
Directeur/Bestuurslid | 29-04-2011 | 29-03-2013 | |
Financieel Directeur/CFO | 29-04-2011 | 29-03-2013 | |
President | 29-04-2011 | 29-03-2013 | |
KTV Ltd. | Corporate Officer/Principal | - | - |
Opleiding van Li Deng-Ke
Sichuan Normal University | Undergraduate Degree |
Statistieken
Internationaal
China | 3 |
Verenigde Staten | 2 |
Operationeel
Comptroller/Controller/Auditor | 1 |
Director/Board Member | 1 |
Director of Finance/CFO | 1 |
Sectoraal
Health Technology | 2 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Rich Pharmaceuticals, Inc.
![]() Rich Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rich Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages on developing innovative therapies in oncology. It develops RP-323 for the treatment of Hodgkin’s lymphoma, Acute Myelogenous Leukemia, and to cause elevation of white blood cells in patients depleted of these elements due to various conditions. The company was founded on August 9, 2010 and is headquartered in Beverly Hills, CA. | Health Technology |
KTV Ltd. |
- Beurs
- Insiders
- Li Deng-Ke
- Ervaring